Invesco DWA Healthcare Momentum ETF (PTH) Stock Price

49.2774 ▼ -0.975 (-1.94%)
Open: 50.15 Vol: 9.8K Day's range: 49.18 - 50.3888 Jan 23, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PTH Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 50.22▲ 50.04▲ 49.85▲ 49.60▼ 49.54▼
MA10 49.85▲ 49.68▲ 49.57▲ 49.47▼ 51.03▼
MA20 49.65▲ 49.54▲ 49.49▲ 49.67▼ 48.09▲
MA50 49.60▲ 49.33▲ 49.42▲ 50.84▼ 42.49▲
MA100 49.62▲ 50.16▲ 50.61▼ 47.49▲ 43.11▲
MA200 51.00▼ 50.04▲ 48.91▲ 42.74▲ 41.16▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.098▲ 0.107▲ 0.101▲ 0.049▲ -0.322▼
RSI 64.859▲ 61.636▲ 61.311▲ 45.022▼ 58.928▲
STOCH 96.672▲ 74.324     61.416     60.060     38.434    
WILL %R -8.036▲ -8.036▲ -8.036▲ -48.271     -60.146    
CCI 90.626     121.161▲ 143.894▲ 22.972     -23.005    
Latest Filters Detected On PTH
RSI $PTH RSI(14) Crossed Below 50 Set Alert
MA $PTH Price Crossed Below MA(26) Set Alert
MA $PTH Price Crossed Below MA(13) Set Alert
MA $PTH Price Crossed Below MA(7) Set Alert
Invesco DWA Healthcare Momentum ETF News
Jim Cramer on UiPath: "You might have to wait a little bit longer, but I think the upside is what beckons there"
Thursday, January 22, 2026 12:09 AM
UiPath Inc. (NYSE:PATH) is one of the stocks Jim Cramer recently looked at. Inquiring about the stock, a caller mentioned that the company has “good earnings and a nice pullback.” In response, Cramer ...
Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook
Wednesday, January 21, 2026 06:04 AM
Final EB613 Phase 3 Protocol Submission to FDA Planned for Q1 2026, Following December 19th 2025 FDA Ruling Next-Generation EB613 Phase 1 Bridging Study Progressing with Results Expected During Q1 ...
BridgeBio Pharma’s Encaleret Shows Positive Phase 2 Results, Normalizes Calcium in Post-Surgical Hypoparathyroidism
Tuesday, September 23, 2025 06:58 PM
BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the most promising long-term stocks to buy. On September 6, BridgeBio Pharma announced that its investigational, orally-administered therapy, called ...
PTH historical stock data
date open high low close volume
23/01/26 50.15 50.3888 49.18 49.2774 9,803
22/01/26 50.21 50.85 50.1335 50.2524 6,299
21/01/26 49.585 49.99 49.405 49.9587 8,082
20/01/26 48.24 49.49 48.24 49.4707 44,830
16/01/26 49.66 49.78 49.0651 49.0651 9,984
15/01/26 49.66 49.87 49.43 49.485 2,294
14/01/26 48.85 49.87 48.74 49.8204 5,645
13/01/26 48.2055 48.9475 48.2055 48.9461 21,643
12/01/26 49.38 49.38 47.9101 48.8837 17,920
09/01/26 49.97 50.3553 49.57 49.5756 36,926
Quote Details
52wk Low:33.561
52wk High:54.48
Vol:9.8K
Avg Vol(3m):307.3K
1Y Chng:+14.17%
1M Chng:-5.89%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00